Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2004 Jun;12(2):45–56. doi: 10.1080/10647440400009896

HPV prevalence and concordance in the cervix and oral cavity of pregnant women.

E M Smith 1, J M Ritchie 1, J Yankowitz 1, D Wang 1, L P Turek 1, T H Haugen 1
PMCID: PMC1784596  PMID: 15739817

Abstract

OBJECTIVES: This investigation examined human papillomavirus (HPV) in pregnant women in order to characterize viral prevalence, types and concordance between infection in the cervix and in the oral cavity. METHODS: A total of 577 pregnant women seeking routine obstetric care were evaluated for HPV infection in their cervix during gestation and immediately before delivery, and in the oral cavity during gestation. Male partners present during the gestational clinic visit also provided a specimen from their oral cavity. HPV assessment was performed by PCR, dot blot hybridization and DNA sequencing. A sexual and health questionnaire was completed by the pregnant women. RESULTS: HPV prevalence in women was 29% in the cervix and 2.4% in the oral cavity. Among those with both gestational and delivery specimens, 35% were infected at least once and 20% had infection at both intervals. At delivery, 68% of infected women had an oncogenic HPV type in the cervix. There was no type-specific HPV concordance between the two cervical specimens, nor cervical and oral results in women, nor with cervical and oral findings between partners. CONCLUSION: The lack of association in HPV positivity and types between the cervix and oral cavity in these women suggests that self-inoculation is uncommon. This source of infection does not appear to be from oral contact with a current male partner, since there also was no concordance between partners. These results suggest either other modes of HPV transmission or differences in susceptibility to HPV infection or its clearance in the oral cavity and genital mucosa.

Full Text

The Full Text of this article is available as a PDF (99.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altschul S. F., Madden T. L., Schäffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997 Sep 1;25(17):3389–3402. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bar-Am A., Niv J., Jaffo A., Peyser R. M. Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions. Isr J Med Sci. 1995 Jun;31(6):349–352. [PubMed] [Google Scholar]
  3. Barrasso R., De Brux J., Croissant O., Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med. 1987 Oct 8;317(15):916–923. doi: 10.1056/NEJM198710083171502. [DOI] [PubMed] [Google Scholar]
  4. Brisson J., Bairati I., Morin C., Fortier M., Bouchard C., Christen A., Bernard P., Roy M., Meisels A. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis. 1996 Apr;173(4):794–799. doi: 10.1093/infdis/173.4.794. [DOI] [PubMed] [Google Scholar]
  5. Chan W. K., Klock G., Bernard H. U. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol. 1989 Aug;63(8):3261–3269. doi: 10.1128/jvi.63.8.3261-3269.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang-Claude J., Schneider A., Smith E., Blettner M., Wahrendorf J., Turek L. Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol. 1996 Mar;60(3):355–362. doi: 10.1006/gyno.1996.0055. [DOI] [PubMed] [Google Scholar]
  7. Chehab F. F., Doherty M., Cai S. P., Kan Y. W., Cooper S., Rubin E. M. Detection of sickle cell anaemia and thalassaemias. Nature. 1987 Sep 24;329(6137):293–294. doi: 10.1038/329293b0. [DOI] [PubMed] [Google Scholar]
  8. Gillison M. L., Koch W. M., Capone R. B., Spafford M., Westra W. H., Wu L., Zahurak M. L., Daniel R. W., Viglione M., Symer D. E. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000 May 3;92(9):709–720. doi: 10.1093/jnci/92.9.709. [DOI] [PubMed] [Google Scholar]
  9. Gravitt P. E., Manos M. M. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Sci Publ. 1992;(119):121–133. [PubMed] [Google Scholar]
  10. Hildesheim A., Schiffman M. H., Gravitt P. E., Glass A. G., Greer C. E., Zhang T., Scott D. R., Rush B. B., Lawler P., Sherman M. E. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994 Feb;169(2):235–240. doi: 10.1093/infdis/169.2.235. [DOI] [PubMed] [Google Scholar]
  11. Hippeläinen M. I., Yliskoski M., Syrjänen S., Saastamoinen J., Hippeläinen M., Saarikoski S., Syrjänen K. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis. 1994 Mar-Apr;21(2):76–82. doi: 10.1097/00007435-199403000-00004. [DOI] [PubMed] [Google Scholar]
  12. Ho G. Y., Burk R. D., Klein S., Kadish A. S., Chang C. J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995 Sep 20;87(18):1365–1371. doi: 10.1093/jnci/87.18.1365. [DOI] [PubMed] [Google Scholar]
  13. Kahn M. A., Dockter M. E., Hermann-Petrin J. M. Flow cytometer analysis of oral premalignant lesions: a pilot study and review. J Oral Pathol Med. 1992 Jan;21(1):1–6. doi: 10.1111/j.1600-0714.1992.tb00959.x. [DOI] [PubMed] [Google Scholar]
  14. Kellokoski J., Syrjänen S., Yliskoski M., Syrjänen K. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol Immunol. 1992 Feb;7(1):19–23. doi: 10.1111/j.1399-302x.1992.tb00014.x. [DOI] [PubMed] [Google Scholar]
  15. Kemp E. A., Hakenewerth A. M., Laurent S. L., Gravitt P. E., Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol. 1992 May;79(5 ):649–656. [PubMed] [Google Scholar]
  16. Kokelj F., Baraggino E., Stinco G., Wiesenfeld U. Study of the partners of women with human papillomavirus infection. Int J Dermatol. 1993 Sep;32(9):661–663. doi: 10.1111/j.1365-4362.1993.tb04022.x. [DOI] [PubMed] [Google Scholar]
  17. Lacey J. V., Jr, Brinton L. A., Abbas F. M., Barnes W. A., Gravitt P. E., Greenberg M. D., Greene S. M., Hadjimichael O. C., McGowan L., Mortel R. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1079–1085. [PubMed] [Google Scholar]
  18. Maymon R., Bekerman A., Werchow M., Maymon B. B., Segal R., Faktor J. H. Clinical and subclinical condyloma. Rates among male sexual partners of women with genital human papillomavirus infection. J Reprod Med. 1995 Jan;40(1):31–36. [PubMed] [Google Scholar]
  19. Miletic I. D., Schiffman S. S., Miletic V. D., Sattely-Miller E. A. Salivary IgA secretion rate in young and elderly persons. Physiol Behav. 1996 Jul;60(1):243–248. doi: 10.1016/0031-9384(95)02161-2. [DOI] [PubMed] [Google Scholar]
  20. Morrison E. A., Gammon M. D., Goldberg G. L., Vermund S. H., Burk R. D. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet. 1996 Aug;54(2):125–130. doi: 10.1016/0020-7292(96)02694-x. [DOI] [PubMed] [Google Scholar]
  21. Moscicki A. B., Palefsky J., Smith G., Siboshski S., Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993 Oct;82(4 Pt 1):578–585. [PubMed] [Google Scholar]
  22. Pater A., Bayatpour M., Pater M. M. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol. 1990 Apr;162(4):1099–1103. doi: 10.1016/0002-9378(90)91323-5. [DOI] [PubMed] [Google Scholar]
  23. Rando R. F., Lindheim S., Hasty L., Sedlacek T. V., Woodland M., Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 1989 Jul;161(1):50–55. doi: 10.1016/0002-9378(89)90231-7. [DOI] [PubMed] [Google Scholar]
  24. Schneider A., Hotz M., Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 1987 Aug 15;40(2):198–201. doi: 10.1002/ijc.2910400212. [DOI] [PubMed] [Google Scholar]
  25. Schneider A., Kirchhoff T., Meinhardt G., Gissmann L. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Gynecol. 1992 May;79(5 ):683–688. [PubMed] [Google Scholar]
  26. Sethi S., Müller M., Schneider A., Blettner M., Smith E., Turek L., Wahrendorf J., Gissmann L., Chang-Claude J. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol. 1998 Feb;178(2):360–364. doi: 10.1016/s0002-9378(98)80026-4. [DOI] [PubMed] [Google Scholar]
  27. Shugars D. C., Watkins C. A., Cowen H. J. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age. Gerontology. 2001 Sep-Oct;47(5):246–253. doi: 10.1159/000052808. [DOI] [PubMed] [Google Scholar]
  28. Smith E. M., Hoffman H. T., Summersgill K. S., Kirchner H. L., Turek L. P., Haugen T. H. Human papillomavirus and risk of oral cancer. Laryngoscope. 1998 Jul;108(7):1098–1103. doi: 10.1097/00005537-199807000-00027. [DOI] [PubMed] [Google Scholar]
  29. Smith E. M., Johnson S. R., Cripe T. P., Pignatari S., Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol. 1991 Jun;100(6):479–483. doi: 10.1177/000348949110000610. [DOI] [PubMed] [Google Scholar]
  30. Smith E. M., Johnson S. R., Cripe T., Perlman S., McGuinness G., Jiang D., Cripe L., Turek L. P. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev. 1995;19(2):196–205. [PubMed] [Google Scholar]
  31. Smith E. M., Johnson S. R., Jiang D., Zaleski S., Lynch C. F., Brundage S., Anderson R. D., Turek L. P. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev. 1991;15(5):397–402. [PubMed] [Google Scholar]
  32. Steele Chad, Fidel Paul L., Jr Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002 Feb;70(2):577–583. doi: 10.1128/IAI.70.2.577-583.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Summersgill K. F., Smith E. M., Kirchner H. L., Haugen T. H., Turek L. P. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Sep;90(3):334–339. doi: 10.1067/moe.2000.107359. [DOI] [PubMed] [Google Scholar]
  34. Veress G., Csiky-Mészáros T., Kónya J., Czeglédy J., Gergely L. Follow-up of human papillomavirus (HPV) DNA and local anti-HPV antibodies in cytologically normal pregnant women. Med Microbiol Immunol. 1996 Nov;185(3):139–144. doi: 10.1007/s004300050023. [DOI] [PubMed] [Google Scholar]
  35. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  36. Wallin K. L., Wiklund F., Angström T., Bergman F., Stendahl U., Wadell G., Hallmans G., Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med. 1999 Nov 25;341(22):1633–1638. doi: 10.1056/NEJM199911253412201. [DOI] [PubMed] [Google Scholar]
  37. Watts D. H., Koutsky L. A., Holmes K. K., Goldman D., Kuypers J., Kiviat N. B., Galloway D. A. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol. 1998 Feb;178(2):365–373. doi: 10.1016/s0002-9378(98)80027-6. [DOI] [PubMed] [Google Scholar]
  38. Wheeler C. M., Greer C. E., Becker T. M., Hunt W. C., Anderson S. M., Manos M. M. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol. 1996 Aug;88(2):261–268. doi: 10.1016/0029-7844(96)00120-2. [DOI] [PubMed] [Google Scholar]
  39. Wickenden C., Hanna N., Taylor-Robinson D., Harris J. R., Bellamy C., Carroll P., Malcolm A. D., Coleman D. V. Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med. 1988 Feb;64(1):34–38. doi: 10.1136/sti.64.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Winer Rachel L., Lee Shu-Kuang, Hughes James P., Adam Diane E., Kiviat Nancy B., Koutsky Laura A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003 Feb 1;157(3):218–226. doi: 10.1093/aje/kwf180. [DOI] [PubMed] [Google Scholar]
  41. Ylitalo N., Sørensen P., Josefsson A., Frisch M., Sparén P., Pontén J., Gyllensten U., Melbye M., Adami H. O. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer. 1999 May 5;81(3):357–365. doi: 10.1002/(sici)1097-0215(19990505)81:3<357::aid-ijc8>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  42. de Roda Husman A. M., Walboomers J. M., Hopman E., Bleker O. P., Helmerhorst T. M., Rozendaal L., Voorhorst F. J., Meijer C. J. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol. 1995 Jun;46(2):97–102. doi: 10.1002/jmv.1890460203. [DOI] [PubMed] [Google Scholar]
  43. de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 Apr;76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES